Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives

SV Aronowitz, E Engel-Rebitzer, A Dolan… - Harm reduction …, 2021 - Springer
Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

[HTML][HTML] Trends in engagement with opioid use disorder treatment among Medicaid beneficiaries during the COVID-19 pandemic

AS Tilhou, L Dague, B Saloner, D Beemon… - JAMA Health …, 2022 - jamanetwork.com
Importance Disruptions in care during the COVID-19 pandemic may have decreased access
to care for patients with opioid use disorder. Objective To examine trends in opioid use …

[HTML][HTML] Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program

KM Ward, A Scheim, J Wang, B Cocchiaro… - Drug and Alcohol …, 2022 - Elsevier
Background Medications such as buprenorphine are considered the gold standard for the
treatment of opioid use disorders. This study aimed to determine whether less restrictive …

Opioid use and COVID-19: a secondary analysis of the impact of relaxation of methadone take-home dosing guidelines on use of illicit opioids

V Panwala, E Thorn, S Amiri, ME Socias… - The American Journal …, 2023 - Taylor & Francis
Background: An exemption to existing US regulation of methadone maintenance therapy
after the onset of the COVID− 19 pandemic permitted increased take-home doses beginning …

Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: a narrative review

V Panwala, P Joudrey, M Kowalski, P Bach… - Journal of Substance Use …, 2023 - Elsevier
Introduction In response to the COVID-19 pandemic, countries across the world made
adaptations to policies regulating the provision of methadone maintenance therapy (MMT) to …

Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic

R Li, M Zhao - Current opinion in psychiatry, 2021 - journals.lww.com
Maintaining treatment and prevention programs for opioid use... : Current Opinion in Psychiatry
Maintaining treatment and prevention programs for opioid use disorders during the coronavirus …

[HTML][HTML] “We have to be uncomfortable and creative”: Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness …

SV Aronowitz, E Engel-Rebitzer, M Lowenstein… - … -Qualitative Research in …, 2021 - Elsevier
The COVID-19 pandemic and ensuing service delivery interruptions had serious impacts on
people who use drugs (PWUD) and people experiencing homelessness, including instability …

Shifting medication treatment practices in the COVID-19 pandemic: a statewide survey of Pennsylvania opioid treatment programs

N Krawczyk, H Maniates, E Hulsey… - Journal of addiction …, 2022 - journals.lww.com
Objectives We sought to understand how opioid treatment programs (OTPs) adapted OTP
operations to the COVID-19 pandemic and new federal regulations around methadone and …

Redefining child protection: addressing the harms of structural racism and punitive approaches for birthing people, dyads, and families affected by substance use

SE Wakeman, A Bryant, N Harrison - Obstetrics & Gynecology, 2022 - journals.lww.com
There has been growing attention on the effect of substance use, including opioid use
disorder, on pregnant and birthing people and their infants. Although effective medication …

[HTML][HTML] Urine drug screening in a telehealth setting for the treatment of opioid use disorder

AR Williams, C Rowe, R Gallagher… - JAMA Health …, 2023 - jamanetwork.com
Importance Amid rapid and widespread adoption of telehealth-based opioid treatment
(TBOT), there is an urgent need for rigorous studies exploring the feasibility and …